After exiting its California headquarters, Kronos Bio was based out of 301 Binney Street in Cambridge. Now that space is also ...

Regeneron licensed a weight loss drug and revealed study data for a pair of muscle-preserving medicines. Elsewhere, two neuroscience biotechs cut deals and Bluebird officially went private.

SOMERVILLE, Mass., June 02, 2025--bluebird bio (NASDAQ: BLUE) ("bluebird"), a pioneer in gene therapies for severe genetic diseases, today announced the completion of its sale to funds managed by ...

Investment firms The Carlyle Group Inc. (NASDAQ:CG) and SK Capital Partners, together with Beacon Parent Holdings, L.P., have ...

With a better upfront offer on the table, enough bluebird bio investors have tendered their shares for the company's sale to ...

SK Capital Partners, LP and Beacon Parent Holdings, L.P. today announced that the tender offer commenced on March 7, 2025 to acquire all of the outstanding common stock of bluebird bio, Inc. (NASDAQ: ...

Bluebird Bio Inc. defeated allegations it misled investors over the terms regulators would apply for approving its sickle cell treatment, a federal judge ruled.

BioMarin agreed to shell out approximately $270 million for Inozyme Pharma, a developer whose treatments target the PPi-adenosine pathway, a key regulator of bone health and blood vessel function.

Joshua Cohen is a Boston-based writer who covers health policy. Bluebird bio is a highly innovative biotechnology company which develops gene therapies for several rare genetic disorders and cancers.

Bluebird (BLUE) delivered earnings and revenue surprises of 26.11% and 17.98%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

Shares of bluebird bio, Inc. (NASDAQ:BLUE) soared 50% in pre-market trading on Wednesday after the biotech firm revealed a ...

May 14 (Reuters) - Carlyle Group (CG.O), opens new tab and SK Capital Partners increased their upfront offer to take over gene therapy maker bluebird bio (BLUE.O), opens new tab, the companies ...